Abstract
Clinical studies clearly indicate that endometriosis is a condition associated with high levels of chronic stress. The stress intensity correlates with pain severity and disease extension. However, it is unknown whether chronic stress represents a primary cause of endometriosis and, therefore, if avoiding or treating chronic stress may reduce the risk of developing endometriosis. Repeated, uncontrolled stress either before or after experimental endometriosis induction promotes disease mechanisms and accelerates lesion growth in rodents. Furthermore, patients with endometriosis have a heightened risk of other inflammatory and immune-related diseases, many of which have also been associated with stress. Here, we review the latest evidences regarding the relationship between chronic stress and endometriosis and discuss the potential bidirectional aspect of such association. Further research may clarify if endometriosis is a cause and/or a consequence of stress and whether stress-reducing therapies are effective to mitigate symptoms and slow down the development of endometriotic lesions.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Endometriosis is a chronic gynecological disorder, defined by the presence of endometrial-like tissue outside the uterine cavity [1]. The prevalence of the disease can reach about 10% of reproductive-age women [2, 3], leading to negative physical and psychological impact in patient’s lives [4, 5]. The pathogenesis involves several hormonal, inflammatory, genetic, and epigenetic mechanisms, which may play a role in the establishment and progression of endometriotic lesions and their clinical manifestations [6, 7]. A number of possible endometriosis risk factors have been described by epidemiologic studies, though a real cause-effect association is barely established [8].
Stress is defined as a threat or an anticipation of a threat to an organism’s homeostasis and can be understood as any stimulus, either psychological or physical, capable to promote an unbalance in the body’s environment [9]. The physiological stress response is a quite complex process and involves several metabolic and neurobiological changes, with peripheral and central repercussion. Whenever an acute stressful stimulus occurs, an adaptive response is triggered through the activation of two coordinated brain systems: the sympathetic nervous system (SNS) and the hypothalamus-pituitary-adrenal (HPA) axis. At first, the SNS, by releasing catecholamines, promotes an increase in the systemic inflammatory activity. The HPA axis, in its turn, stimulates glucocorticoid production, which is responsible for counterbalancing the excessive inflammatory response. Both pathways contribute to enhance blood glucose levels, which provides the necessary energy to cope with the stressor [9,10,11,12,13,14].
The characteristics of the stressful stimulus, such as its duration and intensity, and how it is individually perceived, can drastically alter the stress response. For instance, an acute stressor often stimulates the occurrence of a beneficial adaptive response. Conversely, if the same stressor becomes chronic, it can generate an extended catabolic process, predisposing to cumulative damage of cells and organs targeted by the stress hormones, with health consequences such as metabolic and gastrointestinal diseases, hypertension, and immune-inflammatory disorders [14,15,16,17].
In the last years, a number of studies have demonstrated a possible link between high levels of chronic stress and endometriosis. So far, clinical evidence shows that patients with endometriosis report higher levels of perceived stress, anxiety, and depression than healthy women [18, 19]. Stress intensity is positively correlated to the severity of the disease, pain intensity, and emotion regulation, [20,21,22] and the adoption of coping strategies seems to improve the adaptation to stress [23, 24]. Moreover, experimental studies have shown that previous exposure to repeated and excessive stress accelerates the development and increases the severity of endometriosis in rats [25, 26]. However, it is still debatable whether any cause-effect link really exists and which mechanisms explain this relationship.
Both endometriosis and stress are challenging disorders that must be better investigated, individually and together. The present review aims to address the latest evidence regarding the correlation between these two conditions and discuss a putative bidirectional aspect of such association.
Is Endometriosis a Cause of Stress?
Endometriosis has two cardinal symptoms: pelvic pain and infertility [27]. Both symptoms per se are capable of evoking a chronic stress response, but their consequences can also be remarkably stressful, giving rise to a vicious cycle. For instance, infertility provokes family demands and fear of frustrating social expectations [28, 29], whereas pelvic pain causes sexual dysfunction and work absenteeism [30], which all may contribute to generate more anxiety and chronic stress. Endometriosis is also surrounded by uncertainty about the disease progression, the success of treatments, the long-term health risks, and the reproductive future, which can be additional sources of stress [31,32,33]. Furthermore, women with endometriosis experience a delay of 4 to 7 years from first presentation of symptoms to the diagnosis [34, 35], which may further enhance the levels of stress perceived by the patient (Fig. 1).
Objectively assessing the levels of stress that a person is submitted to is not simple, and the two main strategies that have been used in order to reach this purpose are questionnaires and biomarkers. The first ones can evaluate the frequency and intensity of stress symptoms and the amount of psychological stress perceived. The perceived stress scale (PSS), for example, is a validated psychometric instrument that quantifies the frequency of stressful situations in the last month, in particular those characterized by loss of control, unpredictability, and overload. The stress levels measured by PSS can be high or very high in more than 70% of women with endometriosis [21]. The stress intensity is the highest among women with the most severe disease forms [21] and who have been submitted to multiple surgeries [20]. Stress intensity is higher in women with severe pelvic pain and lower in those who adopt good coping strategies [23, 24]. The application of a therapeutic protocol involving physical and psychological therapy on women with endometriosis and chronic pelvic pain was effective in reducing perceived stress, increasing vitality, and improving physical functioning [36].
An indirect measure of stress level is the health-related quality of life (QoL) [5] evaluated by using different tools, including the Short Form Health Survey (SF-36 or SF-12, a 36- or 12-item questionnaire which investigates both physical and mental components of health-related QoL) or those specific for endometriosis, such as the Endometriosis Health Profile [37]. Endometriosis has a significantly negative impact on health-related QoL scores, and the factors involved are mainly linked to pain symptoms [38]. A recent study by Marki et al. reported that both physical pain symptoms and emotional regulation difficulties, the latter being mediated by psychological stress, had a negative impact on health-related QoL of women with endometriosis [22]. In addition, other factors contribute to the psychological health and stress perception of women with endometriosis, such as self-esteem, body esteem, and emotional self-efficacy [39].
The second way to assess the levels of stress is by measuring the products of the stress response cascade. Among the stress biomarkers usually assessed in clinical studies, the most characteristic one is cortisol. In fact, a prolonged and intense stress stimulus may disrupt the HPA axis and alter the normal pattern of cortisol release. Interestingly, the deregulation of the HPA axis can culminate in either an over response (i.e., hypercortisolism) or a paradoxical phenomenon of adrenal fatigue leading to hypocortisolism [15, 17]. In fact, incongruent patterns of cortisol alterations have been observed in women with endometriosis.
Higher hair cortisol levels were found in patients with endometriosis than in healthy women of similar age, parity, education level, and body mass index (BMI) [40]. Similarly, increased serum cortisol levels were detected in infertile women with endometriosis compared to fertile healthy women, and the highest levels were found in those with advanced stage endometriosis [41]. Interestingly, physical and psychological interventions have been shown to normalize salivary cortisol levels of women with endometriosis and chronic pain [36]. On the other hand, some studies have observed the opposite trend [42, 43]. Petrelluzi et al. showed that patients with endometriosis and chronic pelvic pain had low concentrations of salivary cortisol, measured in three samples collected 8 h apart, and a high level of perceived stress, associated with a poor quality of life [42]. Quinones et al. observed among patients with endometriosis an association between salivary hypocortisolism and infertility and dyspareunia, but not dysmenorrhea [43].
The use of cortisol as a stress biomarker has some limitations. The normal release of this glucocorticoid obeys circadian and ultradian pulsatile rhythms, with a wide variation in pulse frequency and amplitude, and can be influenced by external factors. Such variability renders difficult the long-term analysis of cortisol concentrations and the differentiation between acute and chronic stress by using plasma, urine or saliva samples. Cortisol concentration in the scalp hair, in its turn, provides an average measure of free cortisol levels over a period of time, [44] and hence it seems to be more appropriate for measuring chronic stress [10, 40].
Another marker of chronic stress is salivary alpha-amylase, which reflects the adrenergic axis of the stress response [45, 46], but we are not aware of any study on salivary alpha-amylase levels in women with endometriosis. Serum levels of acute stress hormones, such as prolactin and urocortin-1, are elevated in women with endometriosis [47, 48], but no relationship with pain intensity or level of stress response has been evaluated so far in such patients.
Altogether, the available evidence from clinical studies clearly indicates that endometriosis is a condition associated with high levels of stress. Although it is possible to induce from data available that the disease may cause chronic physical and psychological stress, most studies were cross-sectional and thus had no possibility to demonstrate a temporal relationship between the stress response and the evolution of endometriosis. However, the evidence that the stress intensity assessed by PSS decreased 1 month after the surgical treatment of moderate-to-severe endometriosis suggests that treating the disease contributed to reduce the stress levels of the patients [21].
Does Stress Affect the Course of Endometriosis?
The second vector of the equation endometriosis-stress is the possibility that the stress response affects the evolution of endometriosis. Investigating this cause-effect relation is not an easy task because it would require leaving symptomatic patients without treatment. Current diagnostic methods do not provide any screening test for initial endometriosis and therefore render virtually impossible to investigate in humans whether stress is a risk factor for the establishment of endometriotic implants. Despite the lack of any clinical trial that evaluated a direct effect of chronic stress on the onset, progression, and invasiveness of endometriotic lesions, recent studies allow us to hypothesize that such relation might exist.
A retrospective case-control study [49] showed that mothers of women with endometriosis were significantly more likely to have smoked during the patient’s gestation, increasing the risk of antenatal hypoxemia. In addition, those affected reported more frequently perinatal complications during their gestation, such as prematurity, lower birth weight, and preeclampsia [49,50,51]. We therefore hypothesize that the intrauterine and neonatal exposure to prolonged physical stress stimuli could be linked to the future development of endometriosis. In our opinion, the intrinsic mechanisms involved in this process might be diverse from those implicated in adulthood. While in adults the chronic stress response might directly enhance the progression of endometriotic lesions, early in life the remodeling of neurobiological systems responsible for the stress response [11] might induce epigenetic factors predisposing the future onset of the disease.
If chronic stressful events in the perinatal period may increase the risk of endometriosis in the future, we should next consider the same hypothesis regarding stressful events in childhood. In effect, negligence and abuse during childhood may evoke persistent changes in neural and neuroendocrine systems and consequently hyperactivity of the HPA axis. The combination of precocious exposure to adversity and the presence of a genetic predisposition to anxious personality could produce a personal tendency to have exacerbated stress responses to external stimuli [17, 52]. Recently, a prospective cohort study showed that the risk of endometriosis was greater among women with history of severe physical abuse or severe sexual abuse when compared with those not reporting any previous maltreatment. In particular, the risk of laparoscopically confirmed endometriosis increases up to 79% for women reporting severe-chronic abuse of multiple types [53]. Similarly, results from a case-control study showed that childhood sexual abuse, emotional abuse/neglect, and inconsistency experiences were associated with the diagnosis of endometriosis, suggesting the importance of early stress exposure [54].
Furthermore, small body size/low BMI in childhood and adolescence has been linked on one side with chronic stress [55] and on the other side with the risk of endometriosis [56, 57]. In fact, endometriosis was reported to be more common among women who were leaner at 8 years, at menarche, and at 20–25 years [58]. The body size during childhood seems to be so important that those who were the smallest size between 5 and 10 years have an 18% increased risk to develop endometriosis later in life [57]. In addition, an inverse correlation has been shown between BMI during early adulthood and endometriosis development: young women who were underweight had a relative risk of 1.31 to be affected by the disease [56]. Moreover, patients with the lowest BMI (< 18.5) had the highest risk to develop more severe phenotypes, such as deep infiltrating endometriosis [59].
Nevertheless, the association between low BMI and endometriosis remains unexplained (Fig. 2). An enhanced activity of HPA axis has been demonstrated in patients with anorexia nervosa and in high-performance athletes, inducing a condition of chronic stress [55]. Strenuous physical activity has been reported to increase by 16% the risk of endometriosis [60], while leisure activity seems to decrease this risk to some extent [61]. Thus, stress stimuli, linked to dietary restriction or high intensity physical activity, seem to facilitate endometriosis development. Experimentally, Goetz et al. have demonstrated in mice that endometriosis induces weight loss by disrupting hepatic metabolism [62]. They showed a higher expression of four genes related to an anorexigenic effect and a reduced expression of two genes associated with obesity and metabolic disease in mice with induced endometriosis [62]. Surprisingly, caloric restriction promotes autophagy and blocks the lesion growth in this animal model [63].
A number of inflammatory and immune-related conditions have been linked to high levels of perceived stress, while the occurrence of early stressful events and many of them seem to be related to endometriosis as well [52, 64, 65]. A Danish nationwide cohort study showed that women with endometriosis have an increased risk of inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis, even 20 years after diagnosis [66]. Women with endometriosis have also high risk to develop allergic manifestations, such as hay fever, sinus allergic rhinitis, and food allergy [67]. Furthermore, autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, Sjogren’s syndrome, multiple sclerosis, fibromyalgia, and chronic fatigue syndrome, are more likely to be diagnosed in women with endometriosis [68,69,70,71].
Distress and pain symptoms have a negative impact on each other, leading to the so-called sickness response, associated with a vicious cycle caused by the underlying neuroendocrine–immune imbalance [16, 72]. Chronic fatigue syndrome, fibromyalgia, asthma, and rheumatoid arthritis have been associated with hypocortisolism, probably due to receptor resistance mechanisms [73]. Other chronic pelvic pain syndromes such as inflammatory bowel disease and interstitial cystitis seem to cause a hyperactivity of the HPA axis, despite the limited data available [52, 74, 75]. Enhanced cortisol levels have been described, as well, in syndromic mood and anxiety disorders [76].
The chronic pain experienced by patients with endometriosis and other chronic pain disorders might have a psychosomatic component, beyond physical and biomolecular causes. In fact, although endometriosis severity does not correlate with pelvic pain intensity, stress probably does [77, 78]. According to a recent cross-sectional study, more than half of interviewed women with endometriosis resulted positive to mental health disorders as assessed by the Patient Health Questionnaire, whose results strongly correlated with pain severity: women with severe pain had multiple psychiatric diseases, and the somatoform disorder was the most common [19]. Furthermore, anxiety and depression traits and a higher tendency of pain catastrophizing are commonly present in endometriosis patients and can amplify the perception of pain [77, 79, 80]. It is possible that such relationship could lead to the above cited “sickness response,” contributing to the evolution of the disease.
Studies using animal models of endometriosis have also been used to shed light onto the possible effect of stress in the course of endometriosis. Female rats exposed to the stress model of forced swimming during 10 days, and a control group without stress were subsequently grafted with autologous uterine fragments to induce peritoneal endometriosis [25]. Compared to the non-stressed group, the rats that had been previously exposed to swimming stress developed larger and more numerous endometriotic lesions [25]. When applied 2 weeks after the induction of endometriosis, swimming stress also accelerated the growth of endometriotic implants and mast cell infiltration in the implant area, besides increasing the expression of nerve growth factor in the remaining uterine horn [26]. Moreover, when the animal was given the possibility of “controlling” the swimming stress by floating on a platform, the endometriosis lesions evolved similarly to those of non-stressed controls [81]. This suggests that the level of stress controllability appears to modulate the behavior and pathophysiology of endometriosis, offering evidence for potential therapeutic interventions.
Another series of experiments by Guo and coworkers tested the effects of psychological stressors on the development of endometriosis in mouse model. Exposure to a predator outside the mouse’s cage for 24 h every other day for 2 weeks after inducing endometriosis caused a worsening in the evolution of the disease, characterized by faster lesion growth, macrophage infiltration, and increased angiogenesis [82]. Immobilization stress, either before or after endometriosis induction, was able to boost lesion growth and local angiogenesis, an effect that was prevented by treatment with propranolol, indicating that beta-adrenergic input to the endometriotic lesions was involved in the deleterious effects of the stress [83]. Another study on psychological stress and pain perception in mouse model of endometriosis showed that animals subjected to water avoidance stress for 7 days developed more severe symptoms, but interestingly stress reversed the allodynic effect caused by endometriosis, maybe due to the stress-induced analgesia phenomenon [84].
Conclusions
Women with endometriosis have increased stress, as indicated by psychological and endocrine stress measures, and the stress intensity correlates with pain severity and disease extension. On the other hand, chronic stress may represent a primary cause of endometriosis, and, therefore, avoiding or treating chronic stress might potentially reduce the risk of developing endometriosis. Furthermore, perinatal and childhood stress should be considered as risk factors for endometriosis. However, many questions remain to be addressed, in order to clarify the causal link between endometriosis and stress and to assess whether stress-reducing therapies are effective to mitigate symptoms and/or slow down the development of endometriotic lesions.
References
Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Vigano P. Endometriosis. Nat Rev Dis Primers. 2018;4:9.
Morassutto C, Monasta L, Ricci G, Barbone F, Ronfani L. Incidence and estimated prevalence of endometriosis and adenomyosis in Northeast Italy: a data linkage study. PLoS One. 2016;11:e0154227.
Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362:2389–98.
Fuldeore MJ, Soliman AM. Prevalence and symptomatic burden of diagnosed endometriosis in the United States: National Estimates from a cross-sectional survey of 59,411 women. Gynecol Obstet Investig. 2017;82:453–61.
Culley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, et al. The social and psychological impact of endometriosis on women's lives: a critical narrative review. Hum Reprod Update. 2013;19:625–39.
Tosti C, Pinzauti S, Santulli P, Chapron C, Petraglia F. Pathogenetic mechanisms of deep infiltrating endometriosis. Reprod Sci. 2015;22:1053–9.
Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261–75.
Zubrzycka A, Zubrzycki M, Janecka A, Zubrzycka M. New horizons in the etiopathogenesis and non-invasive diagnosis of endometriosis. Curr Mol Med. 2015;15:697–713.
Selye H. A syndrome produced by diverse nocuous agents. 1936. J Neuropsychiatry Clin Neurosci. 1998;10:230–1.
Greff MJE, Levine JM, Abuzgaia AM, Elzagallaai AA, Rieder MJ, van Uum SHM. Hair cortisol analysis: an update on methodological considerations and clinical applications. Clin Biochem. 2018.
Gunnar M, Quevedo K. The neurobiology of stress and development. Annu Rev Psychol. 2007;58:145–73.
Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140:774–815.
Mazure CM, Maciejewski PK, Jacobs SC, Bruce ML. Stressful life events interacting with cognitive/personality styles to predict late-onset major depression. Am J Geriatr Psychiatry. 2002;10:297–304.
Weger M, Sandi C. High anxiety trait: a vulnerable phenotype for stress-induced depression. Neurosci Biobehav Rev. 2018;87:27–37.
Blackburn-Munro G, Blackburn-Munro R. Pain in the brain: are hormones to blame? Trends Endocrinol Metab. 2003;14:20–7.
Menard C, Pfau ML, Hodes GE, Russo SJ. Immune and neuroendocrine mechanisms of stress vulnerability and resilience. Neuropsychopharmacology. 2017;42:62–80.
Tafet GE, Nemeroff CB. The links between stress and depression: psychoneuroendocrinological, genetic, and environmental interactions. J Neuropsychiatry Clin Neurosci. 2016;28:77–88.
Sepulcri Rde P. Do Amaral VF. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol. 2009;142:53–6.
Vannuccini S, Lazzeri L, Orlandini C, Morgante G, Bifulco G, Fagiolini A, et al. Mental health, pain symptoms and systemic comorbidities in women with endometriosis: a cross-sectional study. J Psychosom Obstet Gynaecol. 2018;39:315–20.
Lazzeri L, Orlandini C, Vannuccini S, Pinzauti S, Tosti C, Zupi E, et al. Endometriosis and perceived stress: impact of surgical and medical treatment. Gynecol Obstet Investig. 2015;79:229–33.
Lazzeri L, Vannuccini S, Orlandini C, Luisi S, Zupi E, Nappi RE, et al. Surgical treatment affects perceived stress differently in women with endometriosis: correlation with severity of pain. Fertil Steril. 2015;103:433–8.
Marki G, Bokor A, Rigo J, Rigo A. Physical pain and emotion regulation as the main predictive factors of health-related quality of life in women living with endometriosis. Hum Reprod. 2017;32:1432–8.
Donatti L, Ramos DG, Andres MP, Passman LJ, Podgaec S. Patients with endometriosis using positive coping strategies have less depression, stress and pelvic pain. Einstein (Sao Paulo). 2017;15:65–70.
Zarbo C, Brugnera A, Frigerio L, Malandrino C, Rabboni M, Bondi E, et al. Behavioral, cognitive, and emotional coping strategies of women with endometriosis: a critical narrative review. Arch Womens Ment Health. 2018;21:1–13.
Cuevas M, Flores I, Thompson KJ, Ramos-Ortolaza DL, Torres-Reveron A, Appleyard CB. Stress exacerbates endometriosis manifestations and inflammatory parameters in an animal model. Reprod Sci. 2012;19:851–62.
Cuevas M, Cruz ML, Ramirez AE, Flores I, Thompson KJ, Bayona M, et al. Stress during development of experimental endometriosis influences nerve growth and disease progression. Reprod Sci. 2018;25:347–57.
Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220:354.e1-.e12.
Galhardo A, Moura-Ramos M, Cunha M, Pinto-Gouveia J. The infertility trap: how defeat and entrapment affect depressive symptoms. Hum Reprod. 2016;31:419–26.
Siedentopf F, Tariverdian N, Rucke M, Kentenich H, Arck PC. Immune status, psychosocial distress and reduced quality of life in infertile patients with endometriosis. Am J Reprod Immunol. 2008;60:449–61.
Soliman AM, Coyne KS, Gries KS, Castelli-Haley J, Snabes MC, Surrey ES. The effect of endometriosis symptoms on absenteeism and presenteeism in the workplace and at home. J Manag Care Spec Pharm. 2017;23:745–54.
Luisi S, Pizzo A, Pinzauti S, Zupi E, Centini G, Lazzeri L, et al. Neuroendocrine and stress-related aspects of endometriosis. Neuro Endocrinol Lett. 2015;36:15–23.
Harrison V, Rowan K, Mathias J. Stress reactivity and family relationships in the development and treatment of endometriosis. Fertil Steril. 2005;83:857–64.
Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96:366–73 e8.
Soliman AM, Fuldeore M, Snabes MC. Factors Associated with Time to Endometriosis Diagnosis in the United States. J Womens Health (Larchmt). 2017;26:788–97.
Staal AH, van der Zanden M, Nap AW. Diagnostic delay of endometriosis in the Netherlands. Gynecol Obstet Investig. 2016;81:321–4.
Friggi Sebe Petrelluzzi K, Garcia MC, Petta CA, et al. Physical therapy and psychological intervention normalize cortisol levels and improve vitality in women with endometriosis. J Psychosom Obstet Gynaecol. 2012;33:191–8.
Aubry G, Panel P, Thiollier G, Huchon C, Fauconnier A. Measuring health-related quality of life in women with endometriosis: comparing the clinimetric properties of the endometriosis health Profile-5 (EHP-5) and the EuroQol-5D (EQ-5D). Hum Reprod. 2017;32:1258–69.
Facchin F, Barbara G, Saita E, Mosconi P, Roberto A, Fedele L, et al. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynaecol. 2015;36:135–41.
Facchin F, Barbara G, Dridi D, Alberico D, Buggio L, Somigliana E, et al. Mental health in women with endometriosis: searching for predictors of psychological distress. Hum Reprod. 2017;32:1855–61.
van Aken M, Oosterman J, van Rijn T, Ferdek M, Ruigt G, Kozicz T, et al. Hair cortisol and the relationship with chronic pain and quality of life in endometriosis patients. Psychoneuroendocrinology. 2018;89:216–22.
Lima AP, Moura MD, Rosa e Silva AA. Prolactin and cortisol levels in women with endometriosis. Braz J Med Biol Res. 2006;39:1121–7.
Petrelluzzi KF, Garcia MC, Petta CA, Grassi-Kassisse DM, Spadari-Bratfisch RC. Salivary cortisol concentrations, stress and quality of life in women with endometriosis and chronic pelvic pain. Stress. 2008;11:390–7.
Quinones M, Urrutia R, Torres-Reveron A, Vincent K, Flores I. Anxiety, coping skills and hypothalamus-pituitary-adrenal (HPA) axis in patients with endometriosis. J Reprod Biol Health. 2015;3.
Lee DY, Kim E, Choi MH. Technical and clinical aspects of cortisol as a biochemical marker of chronic stress. BMB Rep. 2015;48:209–16.
Nater UM, Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology. 2009;34:486–96.
Lynch CD, Sundaram R, Maisog JM, Sweeney AM, Buck Louis GM. Preconception stress increases the risk of infertility: results from a couple-based prospective cohort study--the LIFE study. Hum Reprod. 2014;29:1067–75.
Bilibio JP, Souza CA, Rodini GP, Andreoli CG, Genro VK, de Conto E, et al. Serum prolactin and CA-125 levels as biomarkers of peritoneal endometriosis. Gynecol Obstet Investig. 2014;78:45–52.
Maia LM, Rocha AL, Del Puerto HL, Petraglia F, Reis FM. Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women. Gynecol Endocrinol. 2018;34:202–5.
Vannuccini S, Lazzeri L, Orlandini C, Tosti C, Clifton VL, Petraglia F. Potential influence of in utero and early neonatal exposures on the later development of endometriosis. Fertil Steril. 2016;105:997–1002.
Upson K, Sathyanarayana S, Scholes D, Holt VL. Early-life factors and endometriosis risk. Fertil Steril. 2015;104:964–71.e5.
Borghese B, Sibiude J, Santulli P, et al. Low birth weight is strongly associated with the risk of deep infiltrating endometriosis: results of a 743 case-control study. PLoS One. 2015;10:e0117387.
Fuentes IM, Christianson JA. The influence of early life experience on visceral pain. Front Syst Neurosci. 2018;12:2.
Harris HR, Wieser F, Vitonis AF, Rich-Edwards J, Boynton-Jarrett R, Bertone-Johnson ER, et al. Early life abuse and risk of endometriosis. Hum Reprod. 2018;33:1657–68.
Liebermann C, Kohl Schwartz AS, Charpidou T, et al. Maltreatment during childhood: a risk factor for the development of endometriosis? Hum Reprod. 2018.
Lo Sauro C, Ravaldi C, Cabras PL, Faravelli C, Ricca V. Stress, hypothalamic-pituitary-adrenal axis and eating disorders. Neuropsychobiology. 2008;57:95–115.
Shah DK, Correia KF, Vitonis AF, Missmer SA. Body size and endometriosis: results from 20 years of follow-up within the Nurses' health study II prospective cohort. Hum Reprod. 2013;28:1783–92.
Vitonis AF, Baer HJ, Hankinson SE, Laufer MR, Missmer SA. A prospective study of body size during childhood and early adulthood and the incidence of endometriosis. Hum Reprod. 2010;25:1325–34.
Farland LV, Missmer SA, Bijon A, Gusto G, Gelot A, Clavel-Chapelon F, et al. Associations among body size across the life course, adult height and endometriosis. Hum Reprod. 2017;32:1732–42.
Lafay Pillet MC, Schneider A, Borghese B, Santulli P, Souza C, Streuli I, et al. Deep infiltrating endometriosis is associated with markedly lower body mass index: a 476 case-control study. Hum Reprod. 2012;27:265–72.
Vitonis AF, Maruti SS, Hankinson SE, Hornstein MD, Missmer SA. Adolescent physical activity and endometriosis risk. J Endometr. 2009;1:157–63.
Garavaglia E, Ricci E, Chiaffarino F, et al. Leisure and occupational physical activity at different ages and risk of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;183:104–8.
Goetz LG, Mamillapalli R, Taylor HS. Low body mass index in endometriosis is promoted by hepatic metabolic gene dysregulation in mice. Biol Reprod. 2016;95:115.
Yin B, Liu X, Guo SW. Caloric restriction dramatically stalls lesion growth in mice with induced endometriosis. Reprod Sci. 2018;25:1024–36.
Jones GT. Psychosocial vulnerability and early life adversity as risk factors for central sensitivity syndromes. Curr Rheumatol Rev. 2016;12:140–53.
Kvaskoff M, Mu F, Terry KL, Harris HR, Poole EM, Farland L, et al. Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update. 2015;21:500–16.
Jess T, Frisch M, Jorgensen KT, Pedersen BV, Nielsen NM. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut. 2012;61:1279–83.
Bungum HF, Vestergaard C, Knudsen UB. Endometriosis and type 1 allergies/immediate type hypersensitivity: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2014;179:209–15.
Greenbaum H, Weil C, Chodick G, Shalev V, Eisenberg VH. Evidence for an association between endometriosis, fibromyalgia, and autoimmune diseases. Am J Reprod Immunol. 2019:e13095.
Caserta D, Mallozzi M, Pulcinelli FM, Mossa B, Moscarini M. Endometriosis allergic or autoimmune disease: pathogenetic aspects--a case control study. Clin Exp Obstet Gynecol. 2016;43:354–7.
Harris HR, Costenbader KH, Mu F, Kvaskoff M, Malspeis S, Karlson EW, et al. Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses' health study II. Ann Rheum Dis. 2016;75:1279–84.
Nielsen NM, Jorgensen KT, Pedersen BV, Rostgaard K, Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Hum Reprod. 2011;26:1555–9.
Tariverdian N, Theoharides TC, Siedentopf F, Gutiérrez G, Jeschke U, Rabinovich GA, et al. Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol. 2007;29:193–210.
Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.
Videlock EJ, Adeyemo M, Licudine A, et al. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology. 2009;137:1954–62.
Bernstein CN. The brain-gut axis and stress in inflammatory bowel disease. Gastroenterol Clin N Am. 2017;46:839–46.
Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5:374–81.
Martin CE, Johnson E, Wechter ME, Leserman J, Zolnoun DA. Catastrophizing: a predictor of persistent pain among women with endometriosis at 1 year. Hum Reprod. 2011;26:3078–84.
Rocha AL, Vieira EL, Ferreira MC, Maia LM, Teixeira AL, Reis FM. Plasma brain-derived neurotrophic factor in women with pelvic pain: a potential biomarker for endometriosis? Biomark Med. 2017;11:313–7.
McPeak AE, Allaire C, Williams C, Albert A, Lisonkova S, Yong PJ. Pain Catastrophizing and pain health-related quality-of-life in endometriosis. Clin J Pain. 2018;34:349–56.
Lagana AS, La Rosa VL, Rapisarda AMC, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Women's Health. 2017;9:323–30.
Appleyard CB, Cruz ML, Hernandez S, Thompson KJ, Bayona M, Flores I. Stress management affects outcomes in the pathophysiology of an endometriosis model. Reprod Sci. 2015;22:431–41.
Guo SW, Zhang Q, Liu X. Social psychogenic stress promotes the development of endometriosis in mouse. Reprod BioMed Online. 2017;34:225–39.
Long Q, Liu X, Qi Q, Guo SW. Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor beta2. Hum Reprod. 2016;31:2506–19.
Hernandez S, Cruz ML, Seguinot II, Torres-Reveron A, Appleyard CB. Impact of psychological stress on pain perception in an animal model of endometriosis. Reprod Sci. 2017;24:1371–81.
Funding
The authors received no funding to support the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Reis, F.M., Coutinho, L.M., Vannuccini, S. et al. Is Stress a Cause or a Consequence of Endometriosis?. Reprod. Sci. 27, 39–45 (2020). https://doi.org/10.1007/s43032-019-00053-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-019-00053-0